US6407092B1
(en)
|
1999-04-23 |
2002-06-18 |
Pharmacia & Upjohn Company |
Tetracyclic azepinoindole compounds
|
BR0012086A
(pt)
*
|
1999-06-15 |
2002-04-02 |
Bristol Myers Squibb Pharma Co |
Compostos derivados de gama-carbolinas fundidas com heterociclos substituìdos, composição farmacêutica e usos dos compostos
|
JP2004509894A
(ja)
|
2000-09-20 |
2004-04-02 |
ファルマシア・アンド・アップジョン・カンパニー |
置換アゼピノ[4,5−b]インドリン誘導体
|
US6858604B2
(en)
|
2000-11-03 |
2005-02-22 |
Wyeth |
Cyclohepta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives
|
US6759405B2
(en)
|
2000-11-03 |
2004-07-06 |
Wyeth |
Cycloocta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives
|
US6777407B2
(en)
|
2000-11-03 |
2004-08-17 |
Wyeth |
Cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives
|
SE0004245D0
(sv)
|
2000-11-20 |
2000-11-20 |
Pharmacia Ab |
Novel compounds and their use
|
EP1337518B1
(de)
|
2000-11-20 |
2009-06-17 |
Biovitrum AB (publ) |
Piperazinylpyrazinverbindungen als antagonisten des serotonin-5-ht2-rezeptors
|
US6849619B2
(en)
|
2000-12-20 |
2005-02-01 |
Bristol-Myers Squibb Company |
Substituted pyridoindoles as serotonin agonists and antagonists
|
PL366233A1
(en)
|
2000-12-20 |
2005-01-24 |
Bristol-Myers Squibb Company |
Substituted pyridoindoles as serotonin agonists and antagonists
|
BR0210241A
(pt)
*
|
2001-06-01 |
2004-08-10 |
Alcon Inc |
Piranoindazóis e seu uso no tratamento de glaucoma
|
EP1392658A4
(de)
*
|
2001-06-01 |
2004-10-13 |
Alcon Inc |
Neue kondensierte indazole und indole und deren verwendung zur behandlung von glaucom
|
BR0210238A
(pt)
*
|
2001-06-01 |
2004-07-20 |
Alcon Inc |
Novos análogos de aril-amino-propano e seu uso para o tratamento de glaucoma
|
US20030060462A1
(en)
*
|
2001-08-06 |
2003-03-27 |
Hoffman Robert L. |
Therapeutic compounds
|
WO2003014125A1
(en)
*
|
2001-08-06 |
2003-02-20 |
Pharmacia & Upjohn Company |
Therapeutically useful tetracyclic ligands
|
CA2460126A1
(en)
|
2001-09-21 |
2003-03-27 |
Pharmacia & Upjohn Company |
Tricyclic indole derivatives as 5-ht ligands
|
BR0213417A
(pt)
|
2001-10-18 |
2004-11-03 |
Upjohn Co |
Compostos e composições de tetraciclicazaindóis e indolinas tendo atividade de 5-ht e seus usos
|
TWI312781B
(en)
|
2002-04-25 |
2009-08-01 |
|
[1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents
|
TW200307682A
(en)
|
2002-04-25 |
2003-12-16 |
Wyeth Corp |
1,2,3,4,7,8-Hexahydro-6H-[1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents
|
TW200307540A
(en)
|
2002-04-25 |
2003-12-16 |
Wyeth Corp |
[1, 4]Diazocino[7, 8, 1-hi] indole derivatives as antipsychotic and antiobesity agents
|
AU2003243089B2
(en)
|
2002-06-19 |
2010-01-07 |
Biovitrum Ab (Publ) |
Novel compounds, their use and preparation
|
US6958420B2
(en)
*
|
2002-07-19 |
2005-10-25 |
Board Of Trustees Of Michigan State University |
Synthesis of aminoarylboronic esters and substituted anilines from arenes via catalytic C-H activation/borylation/amination and uses thereof
|
MXPA05002259A
(es)
*
|
2002-08-30 |
2005-07-05 |
Alcon Inc |
Compuestos de 5-croman-5-il-etilamina sustituidos y uso para el tratamiento de glaucoma.
|
AU2003300915B2
(en)
|
2002-12-13 |
2008-08-28 |
Alcon, Inc. |
Novel benzopyran analogs and their use for the treatment of glaucoma
|
EP1581221B1
(de)
*
|
2002-12-19 |
2011-05-18 |
Bristol-Myers Squibb Company |
Substituierte tricyclische gamma-carbolineals serotonin-rezeptor-agonisten und antagonisten
|
CL2004000826A1
(es)
|
2003-04-25 |
2005-03-04 |
Pfizer |
Uso de un agonista para el receptor 5-ht2c para preparar un medicamento util en el tratamiento de la incontinencia urinaria provocada por estres, con la condicion de que el agonista no sea 1-[6-cloro-5-(trifluorometil)-2-piridinil]piperazina (org-129
|
US7728155B2
(en)
|
2003-10-24 |
2010-06-01 |
Wyeth Llc |
Dihydrobenzofuranyl alkanamines and methods for using same as cns agents
|
US7476687B2
(en)
|
2003-11-26 |
2009-01-13 |
Alcon, Inc. |
Substituted furo[2,3-g]indazoles for the treatment of glaucoma
|
US6989445B2
(en)
|
2003-12-15 |
2006-01-24 |
Alcon, Inc. |
Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma
|
US7338972B1
(en)
|
2003-12-15 |
2008-03-04 |
Alcon, Inc. |
Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
|
US7129257B1
(en)
|
2003-12-15 |
2006-10-31 |
Alcon, Inc. |
Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
|
US8076352B2
(en)
|
2004-03-15 |
2011-12-13 |
Ptc Therapeutics, Inc. |
Administration of carboline derivatives useful in the treatment of cancer and other diseases
|
US7767689B2
(en)
|
2004-03-15 |
2010-08-03 |
Ptc Therapeutics, Inc. |
Carboline derivatives useful in the treatment of cancer
|
US8076353B2
(en)
|
2004-03-15 |
2011-12-13 |
Ptc Therapeutics, Inc. |
Inhibition of VEGF translation
|
DK1737461T3
(da)
|
2004-03-15 |
2013-03-18 |
Ptc Therapeutics Inc |
Carbolin-derivater til inhibering af angiogenese
|
WO2006009831A1
(en)
|
2004-06-18 |
2006-01-26 |
Wyeth |
Processes for preparing 6-alkyl-5-arylsulfonyl- dihydrophenanthridines
|
WO2006022420A1
(ja)
|
2004-08-25 |
2006-03-02 |
Takeda Pharmaceutical Company Limited |
腹圧性尿失禁の予防・治療剤及びそのスクリーニング方法
|
GT200500317A
(es)
|
2004-11-05 |
2006-10-27 |
|
Proceso para preparar compuestos de quinolina y productos obtenidos de los mismos
|
WO2006062839A1
(en)
|
2004-12-08 |
2006-06-15 |
Alcon, Inc. |
Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
|
AR054849A1
(es)
|
2005-07-26 |
2007-07-18 |
Wyeth Corp |
Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas
|
MX2008009178A
(es)
*
|
2006-01-19 |
2008-12-05 |
Athersys Inc |
Tiofenil y pirrolil acepinas como ligandos del receptor de serotonina 5-ht2c y sus usos.
|
WO2007132841A1
(ja)
|
2006-05-16 |
2007-11-22 |
Takeda Pharmaceutical Company Limited |
縮合複素環化合物およびその用途
|
KR20090047458A
(ko)
|
2006-08-08 |
2009-05-12 |
사노피-아벤티스 |
아릴아미노아릴-알킬-치환된 이미다졸리딘-2,4-디온, 이의 제조방법, 이들 화합물을 포함하는 약제 및 이의 용도
|
KR102065319B1
(ko)
*
|
2007-03-12 |
2020-01-10 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
치환된 헤테로환 융합 감마-카르볼린 합성
|
JP5546451B2
(ja)
|
2007-06-04 |
2014-07-09 |
シナジー ファーマシューティカルズ インコーポレイテッド |
胃腸の障害、炎症、癌および他の障害の処置に有用なグアニル酸シクラーゼのアゴニスト
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
US20100266504A1
(en)
|
2007-11-15 |
2010-10-21 |
Takahiro Matsumoto |
Condensed pyridine derivative and use thereof
|
US8716308B2
(en)
|
2008-01-11 |
2014-05-06 |
Albany Molecular Research, Inc. |
(1-azinone)-substituted pyridoindoles
|
MX347257B
(es)
|
2008-03-12 |
2017-04-20 |
Intra-Cellular Therapies Inc |
Solido de gamma-carbolinas fusionadas con heterociclos substituidos.
|
KR102184038B1
(ko)
*
|
2008-05-27 |
2020-11-27 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
수면 장애 및 다른 장애를 치료하기 위한 방법 및 조성물
|
AU2015218433B2
(en)
*
|
2008-05-27 |
2017-07-27 |
Intra-Cellular Therapies, Inc. |
Methods and compositions for sleep disorders and other disorders
|
AU2009256157B2
(en)
|
2008-06-04 |
2014-12-18 |
Bausch Health Ireland Limited |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
AR072707A1
(es)
|
2008-07-09 |
2010-09-15 |
Sanofi Aventis |
Compuestos heterociclicos, procesos para su preparacion, medicamentos que comprenden estos compuestos y el uso de los mismos
|
WO2010009319A2
(en)
|
2008-07-16 |
2010-01-21 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
|
CA2737031A1
(en)
*
|
2008-09-29 |
2010-04-01 |
Abbott Laboratories |
Indole and indoline derivatives and methods of use thereof
|
US9625475B2
(en)
*
|
2008-09-29 |
2017-04-18 |
Abbvie Inc. |
Indole and indoline derivatives and methods of use thereof
|
WO2010068601A1
(en)
|
2008-12-08 |
2010-06-17 |
Sanofi-Aventis |
A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
|
US8618299B2
(en)
|
2009-07-01 |
2013-12-31 |
Albany Molecular Research, Inc. |
Azinone-substituted azapolycycle MCH-1 antagonists, methods of making, and use thereof
|
WO2011003021A1
(en)
*
|
2009-07-01 |
2011-01-06 |
Albany Molecular Research, Inc. |
Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
|
US8629158B2
(en)
*
|
2009-07-01 |
2014-01-14 |
Albany Molecular Research, Inc. |
Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
|
US8637501B2
(en)
*
|
2009-07-01 |
2014-01-28 |
Albany Molecular Research, Inc. |
Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine MCH-1 antagonists, methods of making, and use thereof
|
JP5663572B2
(ja)
|
2009-07-14 |
2015-02-04 |
アルバニー モレキュラー リサーチ, インコーポレイテッド |
5−ht3受容体モジュレーター、その作製方法、およびその使用
|
WO2011023754A1
(en)
|
2009-08-26 |
2011-03-03 |
Sanofi-Aventis |
Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use
|
WO2011044134A1
(en)
|
2009-10-05 |
2011-04-14 |
Albany Molecular Research, Inc. |
Epiminocycloalkyl(b)indole derivatives as serotonin sub-type 6 (5-ht6) modulators and uses thereof
|
JPWO2011071136A1
(ja)
|
2009-12-11 |
2013-04-22 |
アステラス製薬株式会社 |
線維筋痛症治療剤
|
US9034865B2
(en)
|
2010-02-18 |
2015-05-19 |
Medivation Technologies, Inc. |
Pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use
|
WO2011103485A1
(en)
|
2010-02-18 |
2011-08-25 |
Medivation Technologies, Inc. |
Fused tetracyclic pyrido[4,3-b]indole and pyrido[3,4-b]indole derivatives and methods of use
|
WO2011103460A1
(en)
*
|
2010-02-18 |
2011-08-25 |
Medivation Technologies, Inc. |
Fused tetracyclic pyrido[4,3-b]indole and pyrido[3,4-b]ondole derivatives and methods of use
|
US8993572B2
(en)
*
|
2010-04-22 |
2015-03-31 |
Intra-Cellular Therapies, Inc. |
Pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines derivatives and [1,4]oxazino[2,3,4-hi]pyrido[4,3-b]indole derivatives
|
WO2012030953A1
(en)
|
2010-09-01 |
2012-03-08 |
Arena Pharmaceuticals, Inc. |
5-ht2c receptor agonists in the treatment of disorders ameliorated by reduction of norepinephrine level
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
WO2012088124A2
(en)
|
2010-12-21 |
2012-06-28 |
Albany Molecular Research, Inc. |
Tetrahydro-azacarboline mch-1 antagonists, methods of making, and uses thereof
|
US8697700B2
(en)
|
2010-12-21 |
2014-04-15 |
Albany Molecular Research, Inc. |
Piperazinone-substituted tetrahydro-carboline MCH-1 antagonists, methods of making, and uses thereof
|
CA2823955A1
(en)
|
2011-01-19 |
2012-07-26 |
Albany Molecular Research, Inc. |
Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-ht6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia
|
WO2012112961A1
(en)
|
2011-02-18 |
2012-08-23 |
Medivation Technologies, Inc. |
Compounds and methods of treating hypertension
|
CN103764672A
(zh)
|
2011-03-01 |
2014-04-30 |
辛纳吉制药公司 |
制备鸟苷酸环化酶c激动剂的方法
|
WO2012120055A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
US8901114B2
(en)
|
2011-03-08 |
2014-12-02 |
Sanofi |
Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
|
EP2683698B1
(de)
|
2011-03-08 |
2017-10-04 |
Sanofi |
Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
|
US8828994B2
(en)
|
2011-03-08 |
2014-09-09 |
Sanofi |
Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
|
WO2012120058A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
US8809324B2
(en)
|
2011-03-08 |
2014-08-19 |
Sanofi |
Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
|
US8828995B2
(en)
|
2011-03-08 |
2014-09-09 |
Sanofi |
Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
|
WO2012120057A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
EP2683700B1
(de)
|
2011-03-08 |
2015-02-18 |
Sanofi |
Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
EP2567959B1
(de)
|
2011-09-12 |
2014-04-16 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridin-4-carbonsäureamid-derivate als kinaseinhibitoren
|
KR20140146192A
(ko)
*
|
2012-04-14 |
2014-12-24 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
유기 화합물
|
CA2891122C
(en)
|
2012-11-14 |
2021-07-20 |
The Johns Hopkins University |
Methods and compositions for treating schizophrenia
|
US9822117B2
(en)
*
|
2013-03-04 |
2017-11-21 |
Daya Drug Discoveries, Inc. |
Pyridoindolobenz[b,d]azepine derivatives and uses thereof
|
WO2014151206A1
(en)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
HUE053159T2
(hu)
|
2013-03-15 |
2021-06-28 |
Intra Cellular Therapies Inc |
Szerves vegyületek
|
US10011637B2
(en)
|
2013-06-05 |
2018-07-03 |
Synergy Pharmaceuticals, Inc. |
Ultra-pure agonists of guanylate cyclase C, method of making and using same
|
WO2015066344A1
(en)
|
2013-11-01 |
2015-05-07 |
Arena Pharmaceuticals, Inc. |
5-ht2c receptor agonists and compositions and methods of use
|
CN114366741A
(zh)
|
2013-12-03 |
2022-04-19 |
细胞内治疗公司 |
新方法
|
US9745300B2
(en)
|
2014-04-04 |
2017-08-29 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
US10077267B2
(en)
|
2014-04-04 |
2018-09-18 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
EP3286172B1
(de)
|
2015-04-23 |
2019-06-12 |
Constellation Pharmaceuticals, Inc. |
Lsd1-inhibitoren und verwendungen davon
|
IL260653B2
(en)
|
2016-01-26 |
2023-03-01 |
Intra Cellular Therapies Inc |
Condensed gamma carbonyls are heterocyclically converted
|
ES2879888T3
(es)
|
2016-03-25 |
2021-11-23 |
Intra Cellular Therapies Inc |
Compuestos orgánicos y su uso en el tratamiento o prevención de trastornos del sistema nervioso central
|
WO2017172795A1
(en)
|
2016-03-28 |
2017-10-05 |
Intra-Cellular Therapies, Inc. |
Novel compositions and methods
|
WO2017172784A1
(en)
*
|
2016-03-28 |
2017-10-05 |
Intra-Cellular Therapies, Inc. |
Novel salts and crystals
|
JP6997718B2
(ja)
*
|
2016-03-28 |
2022-01-18 |
イントラ-セルラー・セラピーズ・インコーポレイテッド |
新規共結晶
|
JP7013454B2
(ja)
|
2016-10-12 |
2022-02-15 |
イントラ-セルラー・セラピーズ・インコーポレイテッド |
アモルファス固体分散体
|
ES2961499T3
(es)
|
2016-10-26 |
2024-03-12 |
Constellation Pharmaceuticals Inc |
Inhibidores de LSD1 y usos médicos de los mismos
|
WO2018106916A1
(en)
*
|
2016-12-07 |
2018-06-14 |
Concert Pharmaceuticals, Inc. |
Deuterated quinoxaline compounds
|
US10906906B2
(en)
|
2016-12-29 |
2021-02-02 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
WO2018126140A1
(en)
*
|
2016-12-29 |
2018-07-05 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
BR112019019875A2
(pt)
|
2017-03-24 |
2020-04-22 |
Intra Cellular Therapies Inc |
novas composições e métodos
|
EP3609501A4
(de)
|
2017-04-10 |
2020-08-19 |
Dr. Reddy's Laboratories Limited |
Amorphe form und feste dispersionen von lumateperon
|
BR112020001666A2
(pt)
*
|
2017-07-26 |
2020-07-21 |
Intra-Cellular Therapies, Inc. |
compostos orgânicos
|
IL272252B2
(en)
|
2017-07-26 |
2024-03-01 |
Intra Cellular Therapies Inc |
Transformed histories of gamma-carbolines fused with heterocyclics, pharmaceutical preparations containing them and their use for treatment
|
US10513515B2
(en)
|
2017-08-25 |
2019-12-24 |
Biotheryx, Inc. |
Ether compounds and uses thereof
|
MX2020007271A
(es)
|
2017-09-26 |
2020-08-17 |
Intra Cellular Therapies Inc |
Sales y cristales novedosos.
|
US11655251B2
(en)
|
2017-11-27 |
2023-05-23 |
Egis Gyogyszergyar Zrt. |
Method for the production of lumateperone and its salts
|
WO2019131902A1
(ja)
|
2017-12-27 |
2019-07-04 |
武田薬品工業株式会社 |
腹圧性尿失禁および便失禁の治療薬
|
US11980617B2
(en)
|
2018-03-16 |
2024-05-14 |
Intra-Cellular Therapies, Inc. |
Methods of treating acute depression and/or acute anxiety
|
AU2019240226A1
(en)
|
2018-03-23 |
2020-10-22 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
WO2019241278A1
(en)
|
2018-06-11 |
2019-12-19 |
Intra-Cellular Therapies, Inc. |
Substituted heterocycle fused gamma-carbolines synthesis
|
US11806311B2
(en)
|
2018-06-21 |
2023-11-07 |
Aquestive Therapeutics, Inc. |
System and method for making personalized individual unit doses containing pharmaceutical actives
|
CN109100437A
(zh)
*
|
2018-07-22 |
2018-12-28 |
邯郸学院 |
仲胺类抗抑郁药物的质谱检测方法
|
US11236103B2
(en)
|
2018-07-27 |
2022-02-01 |
Biotheryx, Inc. |
Bifunctional compounds
|
BR112021003655A2
(pt)
|
2018-08-31 |
2021-05-18 |
Intra-Cellular Therapies, Inc. |
métodos novos
|
US10695345B2
(en)
|
2018-08-31 |
2020-06-30 |
Intra-Cellular Therapies, Inc. |
Pharmaceutical capsule compositions comprising lumateperone mono-tosylate
|
BR112021004053A2
(pt)
|
2018-09-07 |
2021-05-25 |
Aquestive Therapeutics, Inc. |
composições de filme oral e formas de dosagem tendo perfis de dissolução de ativo precisos
|
US20220024924A1
(en)
|
2018-11-27 |
2022-01-27 |
Teva Czech Industries S.R.O |
Solid state forms of lumateperone salts and processes for preparation of lumateperone and salts thereof
|
BR112021011792A2
(pt)
|
2018-12-17 |
2021-08-31 |
Intra-Cellular Therapies, Inc. |
Composto orgânico
|
CN113195450B
(zh)
*
|
2018-12-17 |
2024-04-26 |
细胞内治疗公司 |
取代的杂环稠合的γ-咔啉的合成
|
MX2021007141A
(es)
*
|
2018-12-17 |
2021-08-11 |
Intra Cellular Therapies Inc |
Sintesis de gamma-carbolinas fusionadas con heterociclo sustituido.
|
US20220056031A1
(en)
|
2018-12-21 |
2022-02-24 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
WO2020154519A2
(en)
*
|
2019-01-23 |
2020-07-30 |
Intra-Cellular Therapies, Inc. |
Methods of treating addiction
|
CN113784962A
(zh)
|
2019-02-27 |
2021-12-10 |
加利福尼亚大学董事会 |
用于治疗脑部疾病的氮杂环庚三烯并-吲哚类和其他杂环
|
AU2020254812A1
(en)
*
|
2019-04-04 |
2021-11-11 |
Intra-Cellular Therapies, Inc. |
Methods of treating neuropathic pain
|
WO2021007245A1
(en)
|
2019-07-07 |
2021-01-14 |
Intra-Cellular Therapies, Inc. |
Novel methods
|
EP4051235A1
(de)
|
2019-11-01 |
2022-09-07 |
Aquestive Therapeutics, Inc. |
Prodrug-zusammensetzungen und verfahren zur behandlung
|
CN115038451A
(zh)
|
2019-11-14 |
2022-09-09 |
阿奎斯蒂弗医疗股份有限公司 |
多模式组合物和治疗方法
|
US11753419B2
(en)
|
2019-12-11 |
2023-09-12 |
Intra-Cellular Therapies, Inc. |
4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)phenyl)butan-1-one for treating conditions of the central nervous system and cardiac disorders
|
WO2021222150A2
(en)
|
2020-04-28 |
2021-11-04 |
Anwita Biosciences, Inc. |
Interleukin-2 polypeptides and fusion proteins thereof, and their pharmaceutical compositions and therapeutic applications
|
CN116568302A
(zh)
*
|
2020-10-09 |
2023-08-08 |
上海枢境生物科技有限公司 |
杂环取代的稠合γ-咔啉类衍生物、其制备方法、中间体及应用
|
CN112062767B
(zh)
*
|
2020-10-20 |
2022-03-11 |
杭州科巢生物科技有限公司 |
一种卢美哌隆的制备方法及其中间体
|
JP2024505429A
(ja)
|
2021-01-15 |
2024-02-06 |
アクエスティブ セラピューティクス インコーポレイテッド |
プロドラッグ組成物及び治療の方法
|
CA3210706A1
(en)
|
2021-03-09 |
2022-09-15 |
Alexander Mark Schobel |
Dosage forms having equivalent biocomparable profiles
|
CN116444520A
(zh)
*
|
2022-01-14 |
2023-07-18 |
上海科技大学 |
并环哌啶类化合物及其制备方法和用途
|
CN114456149A
(zh)
*
|
2022-02-24 |
2022-05-10 |
中国科学技术大学 |
一种多巴胺drd2受体拮抗剂及其用途
|
WO2023178111A2
(en)
*
|
2022-03-14 |
2023-09-21 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
WO2023178113A2
(en)
*
|
2022-03-14 |
2023-09-21 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
WO2023225620A1
(en)
|
2022-05-18 |
2023-11-23 |
Intra-Cellular Therapies, Inc. |
Novel methods
|